AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$323M |
| 2 |
Visa
V
|
+$288M |
| 3 |
RTX Corp
RTX
|
+$262M |
| 4 |
Aecom
ACM
|
+$250M |
| 5 |
Automatic Data Processing
ADP
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$468M |
| 2 |
RTN
Raytheon Company
RTN
|
+$349M |
| 3 |
JPMorgan Chase
JPM
|
+$280M |
| 4 |
Alibaba
BABA
|
+$206M |
| 5 |
Ulta Beauty
ULTA
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.48% |
| 2 | Healthcare | 16.91% |
| 3 | Financials | 12.2% |
| 4 | Consumer Discretionary | 11.74% |
| 5 | Communication Services | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBMB
1651
DELISTED
CBM Bancorp, Inc.
CBMB
| $2.79M | ﹤0.01% |
226,761
+5,536
| +3% | +$66.2K |
|
1652
HEICO Corp
HEI
$49.7B
| $2.79M | ﹤0.01% |
27,978
+622
| +2% | +$57.4K |
|
1653
Ironwood Pharmaceuticals
IRWD
$630M
| $2.79M | ﹤0.01% |
270,021
+26,261
| +11% | +$269K |
|
1654
Innovative Industrial Properties
IIPR
$1.79B
| $2.79M | ﹤0.01% |
31,635
+6,800
| +27% | +$553K |
|
|
MDC
1655
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.79M | ﹤0.01% |
84,248
+7,415
| +10% | +$205K |
|
1656
Credit Acceptance
CACC
$5.77B
| $2.77M | ﹤0.01% |
6,621
+646
| +11% | +$225K |
|
|
ATH
1657
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $2.77M | ﹤0.01% |
88,948
+196
| +0.2% | +$5.48K |
|
1658
AtriCure
ATRC
$1.96B
| $2.77M | ﹤0.01% |
61,600
+3,700
| +6% | +$161K |
|
1659
Glaukos
GKOS
$8.73B
| $2.77M | ﹤0.01% |
71,986
+13,570
| +23% | +$505K |
|
1660
BWX Technologies
BWXT
$15.2B
| $2.76M | ﹤0.01% |
48,801
+4,351
| +10% | +$243K |
|
|
FLOW
1661
DELISTED
SPX FLOW, Inc.
FLOW
| $2.76M | ﹤0.01% |
73,835
+6,490
| +10% | +$212K |
|
|
CVET
1662
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.76M | ﹤0.01% |
154,355
+63,518
| +70% | +$835K |
|
|
CIM
1663
Chimera Investment
CIM
$1.06B
| $2.76M | ﹤0.01% |
95,700
+54,560
| +133% | +$1.4M |
|
|
HTO
1664
H2O America
HTO
$2.78B
| $2.75M | ﹤0.01% |
44,300
-37
| -0.1% | -$2.22K |
|
|
MYOV
1665
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.74M | ﹤0.01% |
+133,082
| New | +$1.81M |
|
1666
Rambus
RMBS
$9.47B
| $2.74M | ﹤0.01% |
180,048
+21,304
| +13% | +$300K |
|
1667
Mesa Laboratories
MLAB
$542M
| $2.74M | ﹤0.01% |
12,618
+40
| +0.3% | +$9.22K |
|
|
VIE
1668
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $2.71M | ﹤0.01% |
62,578
+11,759
| +23% | +$532K |
|
1669
Transocean
RIG
$5.62B
| $2.71M | ﹤0.01% |
1,480,023
+477,910
| +48% | +$742K |
|
1670
TechnipFMC
FTI
$29B
| $2.71M | ﹤0.01% |
531,955
-54,061
| -9% | -$315K |
|
1671
Hercules Capital
HTGC
$3B
| $2.71M | ﹤0.01% |
258,404
+6,000
| +2% | +$60.9K |
|
1672
LGI Homes
LGIH
$1.45B
| $2.7M | ﹤0.01% |
30,650
+2,810
| +10% | +$197K |
|
1673
Northwest Natural Holdings
NWN
$2.21B
| $2.69M | ﹤0.01% |
48,254
+3,366
| +7% | +$206K |
|
1674
Amalgamated Financial
AMAL
$1.48B
| $2.69M | ﹤0.01% |
212,863
+16,598
| +8% | +$176K |
|
|
PRNB
1675
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.69M | ﹤0.01% |
45,000
+23,100
| +105% | +$1.43M |
|
Similar funds
AllianceBernstein's Q2 2020 Portfolio in Review
As of Q2 2020, AllianceBernstein held 3,348 positions worth $170B, up 22% from $139B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q2 2020 filing shows 216 new, 1,761 increased, 1,112 reduced and 154 closed positions. Its largest new stake was Otis Worldwide: 6,236,857 shares worth $355M. The largest sale was Berkshire Hathaway Class B, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q2 2020 buy was Otis Worldwide: 6,236,857 shares worth $355M.
- AllianceBernstein added most to Visa in Q2 2020, an estimated $288M increase.
- AllianceBernstein's biggest Q2 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $468M.
- AllianceBernstein fully exited Raytheon Company in Q2 2020, selling an estimated $349M.
- AllianceBernstein's ten largest holdings make up 23% of its $170B portfolio in Q2 2020.
- AllianceBernstein opened 216 new positions and closed 154 in Q2 2020.
- AllianceBernstein's portfolio value rose 22% quarter-over-quarter to $170B.
Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.